AU2007256377B2 - Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma - Google Patents

Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma Download PDF

Info

Publication number
AU2007256377B2
AU2007256377B2 AU2007256377A AU2007256377A AU2007256377B2 AU 2007256377 B2 AU2007256377 B2 AU 2007256377B2 AU 2007256377 A AU2007256377 A AU 2007256377A AU 2007256377 A AU2007256377 A AU 2007256377A AU 2007256377 B2 AU2007256377 B2 AU 2007256377B2
Authority
AU
Australia
Prior art keywords
antibody
annexin
cancer
dsm
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007256377A
Other languages
English (en)
Other versions
AU2007256377A1 (en
Inventor
Andre Schrattenholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteoSys AG
Original Assignee
ProteoSys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteoSys AG filed Critical ProteoSys AG
Publication of AU2007256377A1 publication Critical patent/AU2007256377A1/en
Application granted granted Critical
Publication of AU2007256377B2 publication Critical patent/AU2007256377B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2007256377A 2006-06-09 2007-06-11 Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma Ceased AU2007256377B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US60/812,089 2006-06-09
US85948906P 2006-11-17 2006-11-17
US60/859,489 2006-11-17
PCT/EP2007/005134 WO2007141043A2 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma

Publications (2)

Publication Number Publication Date
AU2007256377A1 AU2007256377A1 (en) 2007-12-13
AU2007256377B2 true AU2007256377B2 (en) 2012-11-01

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007256377A Ceased AU2007256377B2 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma

Country Status (13)

Country Link
US (1) US8012697B2 (enExample)
EP (1) EP2024748B1 (enExample)
JP (1) JP2009540278A (enExample)
KR (1) KR20090023372A (enExample)
AU (1) AU2007256377B2 (enExample)
CA (1) CA2654330A1 (enExample)
DE (1) DE07725949T1 (enExample)
DK (1) DK2024748T3 (enExample)
ES (1) ES2396730T3 (enExample)
PL (1) PL2024748T3 (enExample)
PT (1) PT2024748E (enExample)
RU (1) RU2467335C2 (enExample)
WO (1) WO2007141043A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP2344544A2 (en) * 2008-09-26 2011-07-20 ProteoSys AG Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) * 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) * 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
US9487831B2 (en) * 2013-09-12 2016-11-08 Versitech Limited Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
WO2005078124A2 (de) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs
WO2006125580A1 (en) * 2005-05-21 2006-11-30 Proteosys Ag Annexin for cancer risk assessment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
WO2005078124A2 (de) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs
WO2006125580A1 (en) * 2005-05-21 2006-11-30 Proteosys Ag Annexin for cancer risk assessment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Madoz-Gurpide, J. et al. Molecular & Cellular Proteomics (2006) vol. 5 pages 1471-1483. *

Also Published As

Publication number Publication date
DE07725949T1 (de) 2009-07-02
CA2654330A1 (en) 2007-12-13
WO2007141043A2 (en) 2007-12-13
DK2024748T3 (da) 2013-03-18
US20100233160A1 (en) 2010-09-16
US8012697B2 (en) 2011-09-06
PT2024748E (pt) 2013-01-16
RU2008152009A (ru) 2010-07-20
WO2007141043A3 (en) 2008-03-20
EP2024748A2 (en) 2009-02-18
RU2467335C2 (ru) 2012-11-20
EP2024748B1 (en) 2012-12-12
KR20090023372A (ko) 2009-03-04
PL2024748T3 (pl) 2013-05-31
JP2009540278A (ja) 2009-11-19
ES2396730T3 (es) 2013-02-25
AU2007256377A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
KR102159773B1 (ko) 글리피칸-3에 대한 고친화력 단클론 항체 및 이의 용도
AU2007256377B2 (en) Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma
KR101674097B1 (ko) 췌장, 난소 및 다른 암의 검출 및 치료
Cozzi et al. MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer
JP4813661B2 (ja) 癌を診断するための方法および組成物
ES2748397T3 (es) Uso de HE4 y otros marcadores bioquímicos para la evaluación de cánceres de ovario
WO2014133093A1 (ja) 不溶性フィブリンに対する抗体
EP1350085A2 (en) Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
AU2005231081A1 (en) RM2 antigen (beta1,4-GaINAc-disialyl-Lc4) as prostate cancer-associated antigen
AU2008284271B2 (en) Matriptase protein and uses thereof
JP2007534307A (ja) 分泌性白血球プロテアーゼインヒビターに対する抗体
JP2019501901A (ja) 炎症性腸疾患の治療及び診断のための抗体
JP2008539271A (ja) ｃｓＰＣＮＡイソ型抗体およびその使用
WO2003086456A2 (en) Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
JP5683948B2 (ja) 糖を含有する全ての（ｐａｎ）癌のマーカー
KR20120095301A (ko) 항-사이토케라틴 8/18 복합체 자가면역항체를 포함하는 암 진단 마커 및 이의 항원을 포함하는 암 진단용 조성물
US20110177536A1 (en) Novel antibodies recognizing native annexin a3
CN101501501A (zh) 用于检测前列腺癌的抗膜联蛋白a3单克隆抗体
US20100254898A1 (en) ANTIBODIES THAT BIND GalNAc1-3Gal, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME
US20230340147A1 (en) Antibodies specific for alpha-1,6-core-fucosylated psa and fucosylated fragments thereof
HK1176940B (en) Monoclonal antibodies and diagnostic uses thereof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired